Concepedia

Dagmar Clemens

DC

Statistics

Publications

5

Citations

114

H-Index

5

Active since

2014

Affiliations

University Hospital Münster(Current)

Dagmar Clemens is an author at University Hospital Münster specializing in medicine, oncology, and pharmacology.

Publications per year

2014–2018

5

Publications

5

The CXCR4 antagonist plerixafor (AMD3100) promotes proliferation of Ewing sarcoma cell lines in vitro and activates receptor tyrosine kinase signaling

Philipp Berning, Christiane Schaefer, Dagmar Clemens et al. · Cell Communication and Signaling · 2018 · 29 citations · Full text

, , +17

Analysis of the antiproliferative effects of 3-deazaneoplanocin A in combination with standard anticancer agents in rhabdoid tumor cell lines

Rebekka Unland, Christiane Borchardt, Dagmar Clemens et al. · Anti-Cancer Drugs · 2014 · 26 citations

, , +15

Suberanilohydroxamic acid (vorinostat) synergistically enhances the cytotoxicity of doxorubicin and cisplatin in osteosarcoma cell lines

Aleksandra Pettke, Marc Hotfilder, Dagmar Clemens et al. · Anti-Cancer Drugs · 2016 · 21 citations

, , +14

Anchorage-independent growth of Ewing sarcoma cells under serum-free conditions is not associated with stem-cell like phenotype and function

Katharina Leuchte, Bianca Altvater, Simeon Hoffschlag et al. · Oncology Reports · 2014 · 20 citations · Full text

, , +13

Suberoylanilide hydroxamic acid synergistically enhances the antitumor activity of etoposide in Ewing sarcoma cell lines

Rebekka Unland, Dagmar Clemens, Ulrike Heinicke et al. · Anti-Cancer Drugs · 2015 · 18 citations

, , +17

1–5 of 5